You have 9 free searches left this month | for more free features.

combination

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myeloproliferative Diseases Trial in Houston (Ruxolitinib, Lenalidomide, Prednisone)

Completed
  • Myeloproliferative Diseases
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 8, 2019

Acute Myeloid Leukemia Trial in Hershey (Avelumab)

Terminated
  • Acute Myeloid Leukemia
  • Hershey, Pennsylvania
    Penn State Cancer Institute
Aug 19, 2019

Metabolic Syndrome, Hypertriglyceridemia Trial in Sioux Falls (omega-3 acid ethyl esters, extended release niacin, )

Completed
  • Metabolic Syndrome
  • Hypertriglyceridemia
  • omega-3 acid ethyl esters
  • +3 more
  • Sioux Falls, South Dakota
    Sanford Clinic Clinical Research Services
Sep 28, 2021

Comparative Effectiveness of COPD Treatments

Completed
  • Pulmonary Disease, Chronic Obstructive
  • LABA and the LAMA tiotropium (LABA-TIO)
  • LABA and an ICS (LABA-ICS)
  • Montreal, Canada
    Centre for Clinical Epidemiology, McGill University
Jul 10, 2019

Melanoma Trial in Omaha (Pembrolizumab, Interleukin-2)

Terminated
  • Melanoma
  • Omaha, Nebraska
    Nebraska Cancer Specialists
Oct 18, 2019

Metastatic Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Intensity-modulated radiotherapy concurrent with capecitabine)

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • Intensity-modulated radiotherapy concurrent with capecitabine
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer center
Aug 21, 2022

Epidermoid Carcinoma, Anus Trial in France (radiochemo, Panitumumab)

Completed
  • Epidermoid Carcinoma
  • Anus
  • Bordeaux, France
  • +14 more
Mar 23, 2022

Pulmonary Cancer Trial (Laser Speckle Contrast Imaging using the PerfusiX-Imaging Device)

Recruiting
  • Pulmonary Cancer
  • Laser Speckle Contrast Imaging using the PerfusiX-Imaging Device
  • Leeuwarden, Friesland, Netherlands
    Medical Center Leeuwarden
Jan 5, 2023

Carbapenem Resistant Bacterial Infection, Acinetobacter Bacteremia, Acinetobacter Pneumonia Trial (Cefiderocol,

Not yet recruiting
  • Carbapenem Resistant Bacterial Infection
  • +2 more
  • (no location specified)
Jun 18, 2023

Tumors, Breast Trial in Worldwide (lapatinib, trastuzumab, Aromatase inhibitor)

Active, not recruiting
  • Neoplasms, Breast
  • La Jolla, California
  • +229 more
Aug 27, 2021

Cardiac Surgery Trial in Beijing (Nirmatrelvir/ritonavir, Ursodeoxycholic acid)

Recruiting
  • Cardiac Surgery
  • Beijing, Beijing, China
    Fuwai Hospital
Jan 18, 2023

Cerebrovascular Accident Trial in Cleveland (upper limb rehabilitation for chronic stroke)

Completed
  • Cerebrovascular Accident
  • upper limb rehabilitation for chronic stroke
  • Cleveland, Ohio
    Louis Stokes Cleveland Department of Veterans Affairs Medical Ce
Apr 4, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in

Terminated
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Network
Oct 30, 2019

Myocarditis, Cardiac Sarcoidosis, Pericarditis Trial in Bern

Enrolling by invitation
  • Myocarditis
  • +2 more
    • Bern, Switzerland
      Department of Cardiology, University Hospital Bern, Inselspital,
    May 17, 2022

    Endometrial Cancer Trial in Norway, United States (drug, procedure, radiation)

    Completed
    • Endometrial Cancer
    • Los Angeles, California
    • +28 more
    Oct 21, 2020

    Drug Interaction Trial in Ile-Ife (Nitazoxanide, "Nitazoxanide" and "atazanavir/ritonavir" separately)

    Active, not recruiting
    • Drug Interaction
    • Nitazoxanide
    • "Nitazoxanide" and "atazanavir/ritonavir" separately
    • Ile-Ife, Osun, Nigeria
      Obafemi Awolowo University
    Jan 8, 2023

    Pseudomyxoma Peritonei, Peritoneal Cancer, Mucinous Adenocarcinoma Trial (Bromelain, Acetylcysteine, Interventional radiology

    Not yet recruiting
    • Pseudomyxoma Peritonei
    • +3 more
    • (no location specified)
    Feb 28, 2022

    The PROMISE Pediatric Study 6 to 11 Years Old

    Active, not recruiting
    • Cystic Fibrosis
    • Cystic Fibrosis in Children
      • Birmingham, Alabama
      • +19 more
      Sep 7, 2022

      Metabolic Health Trial in Bothell (VIOME Precision Nutrition Program, VIOME-designed condition-based supplements)

      Not yet recruiting
      • Metabolic Health
      • VIOME Precision Nutrition Program
      • VIOME-designed condition-based supplements
      • Bothell, Washington
        Viome Life Sciences
      Dec 23, 2022

      Non-Alcoholic Fatty Liver Disease Trial in Kurdistan (Multiviamins and minerals, Placebo)

      Completed
      • Non-Alcoholic Fatty Liver Disease
      • Multiviamins and minerals
      • Placebo
      • Kurdistan, Kalar, Iraq
        Hawal Fateh
      Jun 8, 2023

      Generalized Anxiety Disorder Trial in Toronto (Dietary Counselling combined with Omega-3 Supplementation)

      Recruiting
      • Generalized Anxiety Disorder
      • Dietary Counselling combined with Omega-3 Supplementation
      • Toronto, Ontario, Canada
        Canadian College of Naturopathic Medicine
      Jan 10, 2023

      Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)

      Active, not recruiting
      • Lymphoma, Large B-Cell, Diffuse
      • Santa Barbara, California
      • +22 more
      Jan 25, 2023

      Hepatitis B, Chronic Trial in Auckland (VIR-3434, VIR-2218, TDF)

      Recruiting
      • Hepatitis B, Chronic
      • Auckland, New Zealand
      • +1 more
      Dec 19, 2022

      Idiopathic Pulmonary Hemosiderosis, Leflunomide Trial in Guangzhou (Leflunomide, Steroid Drug)

      Recruiting
      • Idiopathic Pulmonary Hemosiderosis
      • Leflunomide
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital of Sun Yat-sen University
      Jun 30, 2023

      Postoperative Recurrence by Intestinal Ultrasound After

      Recruiting
      • Crohn Disease
      • Intestinal ultrasound
      • Lüneburg, Germany
      • +4 more
      Jan 27, 2023